KTRA logo

Kintara Therapeutics (KTRA) Long Term Liabilities

Annual Total Long Term Liabilities

$186.00 K
+$20.00 K+12.05%

01 June 2024

KTRA Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$186.00 K
+$3000.00+1.64%

01 June 2024

KTRA Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KTRA Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+12.1%+11.4%
3 y3 years+2.2%+3.9%
5 y5 years+100.0%+100.0%

KTRA Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time-96.2%-98.6%

Kintara Therapeutics Long Term Liabilities History

DateAnnualQuarterly
June 2024
$186.00 K(+12.0%)
$186.00 K(+1.6%)
Mar 2024
-
$183.00 K(+2.2%)
Dec 2023
-
$179.00 K(+7.2%)
Sept 2023
-
$167.00 K(+0.6%)
June 2023
$166.00 K(+1.8%)
$166.00 K(+1.2%)
Mar 2023
-
$164.00 K(+105.0%)
Dec 2022
-
$80.00 K(+5.3%)
Sept 2022
-
$76.00 K(-53.4%)
June 2022
$163.00 K(-10.4%)
$163.00 K(-5.2%)
Mar 2022
-
$172.00 K(-3.4%)
Dec 2021
-
$178.00 K(-0.6%)
Sept 2021
-
$179.00 K(-1.6%)
June 2021
$182.00 K(>+9900.0%)
$182.00 K(-9.9%)
Mar 2021
-
$202.00 K(+14.1%)
Dec 2020
-
$177.00 K(-5.9%)
Sept 2020
-
$188.00 K(>+9900.0%)
June 2020
$0.00(0.0%)
$0.00(0.0%)
Mar 2020
-
$0.00(0.0%)
Dec 2019
-
$0.00(0.0%)
Sept 2019
-
$0.00(0.0%)
June 2019
$0.00(-100.0%)
$0.00(-100.0%)
Mar 2019
-
$300.00(+200.0%)
Dec 2018
-
$100.00(-92.3%)
Sept 2018
-
$1300.00(+18.2%)
June 2018
$1100.00(-96.1%)
$1100.00(-67.6%)
Mar 2018
-
$3400.00(-38.2%)
Dec 2017
-
$5500.00(+34.1%)
Sept 2017
-
$4100.00(-85.4%)
DateAnnualQuarterly
June 2017
$28.10 K(-96.8%)
$28.10 K(-69.3%)
Mar 2017
-
$91.50 K(-46.6%)
Dec 2016
-
$171.20 K(-71.0%)
Sept 2016
-
$590.30 K(-32.1%)
June 2016
$869.60 K(-65.8%)
$869.60 K(-25.5%)
Mar 2016
-
$1.17 M(-23.8%)
Dec 2015
-
$1.53 M(-51.1%)
Sept 2015
-
$3.13 M(+23.2%)
June 2015
$2.54 M(-33.5%)
$2.54 M(+52.6%)
Mar 2015
-
$1.67 M(-4.6%)
Dec 2014
-
$1.75 M(-52.0%)
Sept 2014
-
$3.64 M(-42.9%)
June 2014
$3.82 M(-21.8%)
-
Mar 2014
-
$6.37 M(+30.4%)
Dec 2013
$4.89 M(>+9900.0%)
$4.89 M(-7.3%)
Sept 2013
-
$5.27 M(-61.2%)
June 2013
-
$13.57 M(+53.5%)
Mar 2013
-
$8.84 M(>+9900.0%)
Dec 2012
-
$0.00(0.0%)
Sept 2012
-
$0.00(0.0%)
June 2012
-
$0.00(0.0%)
June 2012
$0.00(0.0%)
-
Mar 2012
-
$0.00(0.0%)
Dec 2011
-
$0.00(0.0%)
Sept 2011
-
$0.00(0.0%)
June 2011
$0.00(0.0%)
$0.00(0.0%)
Mar 2011
-
$0.00(0.0%)
Dec 2010
-
$0.00(0.0%)
June 2010
$0.00
$0.00

FAQ

  • What is Kintara Therapeutics annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Kintara Therapeutics?
  • What is Kintara Therapeutics annual total long term liabilities year-on-year change?
  • What is Kintara Therapeutics quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Kintara Therapeutics?
  • What is Kintara Therapeutics quarterly long term liabilities year-on-year change?

What is Kintara Therapeutics annual total long term liabilities?

The current annual total long term liabilities of KTRA is $186.00 K

What is the all time high annual total long term liabilities for Kintara Therapeutics?

Kintara Therapeutics all-time high annual total long term liabilities is $4.89 M

What is Kintara Therapeutics annual total long term liabilities year-on-year change?

Over the past year, KTRA annual total long term liabilities has changed by +$20.00 K (+12.05%)

What is Kintara Therapeutics quarterly total long term liabilities?

The current quarterly long term liabilities of KTRA is $186.00 K

What is the all time high quarterly long term liabilities for Kintara Therapeutics?

Kintara Therapeutics all-time high quarterly total long term liabilities is $13.57 M

What is Kintara Therapeutics quarterly long term liabilities year-on-year change?

Over the past year, KTRA quarterly total long term liabilities has changed by +$19.00 K (+11.38%)